Download DNB 2019 Dec 2019 Dec MEDICAL ONCOLOGY PAPER II Question Paper

Download Diplomate in National Board (DNB) 2019 Dec 2019 Dec MEDICAL ONCOLOGY PAPER II Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2019
MEDICAL ONCOLOGY
PAPER?II
Time: 3 hours MED.ONCO/D/19/17/Il
Max. Marks:100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and leg/b/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al/ the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
. Draw tab/e/diagrams/f/owcharts Wherever appropriate.
Write short notes on:
1. a) What is minimal residual disease(MRD) in acute leukemia? 2+4+4
b) Various methods of detection, cut off value and limitations of
MRD in acute lymphoblastic leukemia.
C) Prognostic and therapeutic implications of MRD in acute
lymphoblastic leukemia.
2. a) Solitary pulmonary nodule. 4+3+3
b) Growing teratoma syndrome.
0) Port site metastasis.
3. 3) Differential diagnosis of pulmonary infiltrates in cancer patients. 3+4+3
b) Evaluation and management of pulmonary infiltrate in cancer
patients.
0) Describe chemotherapy related pulmonary toxicity.
4. a) Indications of radionuclide bone scan in oncology practice. 3+2+5
b) What is a superscan?
0) Management of metastatic bone disease.
5. a) What are tumour markers? 2+4+4
b) Describe in detail the role of tumour markers in gynecological
malignancies.
0) Management of rising CA 125 in previously treated case of
epithelial ovarian cancer.
6. a) Robotic surgery. 3+4+3
b) Video assisted thoracic surgery.
0) Natural orifice transluminal endoscopic surgery(NOTES).
7. a) Management of post chemotherapy residual mass in germ cell 4+3+3 st
tumour. *
b) Types of retroperitoneal lymph node dissection (RPLND).
0) Long term complications of RPLND.
P.T.O
.. | _
POSSESSION/USE 0F (TELL PHONES OR ANYSUCI/ ELECTRONIC GADGETS IS NOT l?ERM/Y??ED INSIDE THE
EX/I M I N A WON HALL,

FINAL EXAM
DECEMBER 2019
10.
NATIONAL BOARD OF EXAMINATIONS
MEDICAL ONCOLOGY
PAPER-II
Endoscopic ultrasound. 2+4+4
Role of endobronchial ultrasound in staging of mediastinal
nodes in non~small cell lung cancer.
BI?RADS classifications for mammography.
Define febrile neutropenia. 2+4+2+2
How will you evaluate and manage patients with febrile
neutropenia in oncology Clinical practice?
Antibiogram.
Pegfilgrastim.
WHO classification of primary brain tumours. 4+4+2
Prognostic and diagnostic molecular markers in primary brain
tumours.
Role of Bevacizumab in glioblastoma multiforme.
***********
-2-
POSSESSION/USE OF CELL PHONES ()R AN Y SUCH ELECTRONIC GADGETS IS NO?I'PER/VIITI'ED INSIDE THE
EXA MlN/l TION 11/! LL,